-
Mashup Score: 13Venetoclax monotherapy for patients with R/R CLL: Results from the phase III VENICE-1 trial - 1 month(s) ago
Here we summarize the results from the VENICE-1 trial evaluating venetoclax monotherapy in patients with R/R CLL, published by Kater et al.1 in Lancet Oncology.
Source: lymphomahub.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 17Venetoclax for del(17p) chronic lymphocytic leukemia: Long-term follow-up data from the M13-982 trial - 2 month(s) ago
Here, we summarize the 6-year follow-up and subgroup analyses from the M13-982 trial that assessed venetoclax monotherapy in patients aged ≥18 years with R/R or previously untreated del(17p) CLL.
Source: lymphomahub.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Pirtobrutinib Inhibits BTK C481 Clones in Patients With CLL - 6 month(s) ago
Among patients with chronic lymphocytic leukemia who progressed after treatment, pirtobrutinib demonstrated a clearance of BTK C481 clones and the development of non-C481 clones.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
Is venetoclax monotherapy beneficial in patients with R/R CLL? Read our summary of the results from the phase III VENICE-1 trial here 👉 https://t.co/v9pryrW2ub #CLL #lymsm https://t.co/ubMch3abzg